Ryanodine receptor 2 (RYR2) mutation: A potentially novel neurocardiac calcium channelopathy manifesting as primary generalised epilepsy
Authors:
- 1 April 2019
- journal article
- research article
- Published by Elsevier in Seizure: European Journal of Epilepsy
- Vol. 67, 11-14
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Novel West syndrome candidate genes in a Chinese cohortCNS Neuroscience & Therapeutics, 2018
- VarCards: an integrated genetic and clinical database for coding variants in the human genomeNucleic Acids Research, 2017
- The N-Terminal Region of the Ryanodine Receptor Affects Channel ActivationFrontiers in Physiology, 2017
- The heart of epilepsy: Current views and future conceptsSeizure: European Journal of Epilepsy, 2017
- Sudden unexpected death in epilepsy genetics: Molecular diagnostics and preventionEpilepsia, 2016
- Cardiac Channel Molecular Autopsy for Sudden Unexpected Death in EpilepsyJournal of Child Neurology, 2010
- The RYR2-Encoded Ryanodine Receptor/Calcium Release Channel in Patients Diagnosed Previously With Either Catecholaminergic Polymorphic Ventricular Tachycardia or Genotype Negative, Exercise-Induced Long QT SyndromeJACC, 2009
- Catecholaminergic polymorphic ventricular tachycardia: RYR2 mutations, bradycardia, and follow up of the patientsJournal of Medical Genetics, 2005
- Juvenile sudden death in a family with polymorphic ventricular arrhythmias caused by a novel RyR2 gene mutation: evidence of specific morphological substratesHuman Pathology, 2005
- Localization of the 12.6-kDa FK506-binding Protein (FKBP12.6) Binding Site to the NH2-terminal Domain of the Cardiac Ca2+ Release Channel (Ryanodine Receptor)Journal of Biological Chemistry, 2003